Unituxin is a GD2-binding monoclonal antibody indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy. UNITUXIN (dinutuximab) injection should be administered under the supervision of a qualified physician experienced in the uses of cancer chemotherapeutic agents.

What is Unituxin used for?

Unituxin (dinutuximab) is indicated, in combination with granulocyte-macrophage colonystimulating factor (GM-CSF), interleukin-2 (IL-2) and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy.

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand UNITUXIN (dinutuximab) injection on prescription and Import License in Patient's Name only.

For Unituxin injection or generic dinutuximab price in India. Please call at M: +91 9811747774 or Email Us to know more details about the medicine and its cost price in India.
UNITUXIN (dinutuximab) injection

Get In Touch

Facilitator under Patient Assistance Programs In India

For Indian Patients, doctors and hospitals UNITUXIN (dinutuximab) injection can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Dosage Forms and Strengths

Injection: 17.5 mg/5 mL (3.5 mg/mL) in a single-use vial.

ReadMore
News/Updates

News/Updates

FDA Approves Unituxin™ (dinutuximab) for the Treatment of Pediatric High-Risk Neuroblastoma

ReadMore